Pro-drugs for indirect cannabinoids as therapeutic agents.

  title={Pro-drugs for indirect cannabinoids as therapeutic agents.},
  author={John Clive Ashton},
  journal={Current drug delivery},
  volume={5 4},
Medicinal cannabis, cannabis extracts, and other cannabinoids are currently in use or under clinical trial investigation for the control of nausea, emesis and wasting in patients undergoing chemotherapy, the control of neuropathic pain and arthritic pain, and the control of the symptoms of multiple sclerosis. The further development of medicinal cannabinoids has been challenged with problems. These include the psychoactivity of cannabinoid CB1 receptor agonists and the lack of availability of… CONTINUE READING